Á¢Çï¸Õ¹ý£¬µ«¶¥×ÅËÄÊ®¶ÈµÄ¸ßΣ¬¡°ÇïÌìµÄµÚÒ»±Ä̲衱»¹ÊǵõãÕý³£±ù¡£ Ðí¶àÈËÎÑÔÚ¿Õµ÷·¿ÀïìÅÄ̲衢Ѽ²±ºÍÆ¡¾Æ£¬ÓÐÒ»¸ö¼²²¡È´Ò²ÇÄÈ»ÕÒÉÏÁËÃÅ£¬²»ÊÇ ¸ßѪÌÇ £¬²»ÊǾƾ«¸Î£¬¶øÊÇÁîÐí¶àÄêÇáÈ˶¼Ä¬Ä¬ÖÐǹµÄ¡°¸ßÄòËᡱ¡£ ¾Ý¹ú¼ÒÎÀ½¡Î¯£¬Öйú¸ßÄòËáÈËȺ±ÈÀýÖðÄêÉÏÕÇ£¬²¢ÇÒ³ÊÏÖÄêÇữÇ÷ÊÆ [1]¡£´óÁ¿ÄêÇáÈË£¬ÓÈÆäÊÇÄÐÉúÒѾÌå¼ì³ö¸ßÄòËᣬ¸ßÄòËáÉõÖÁÆձ鵽¿ÉÒԺ͸ßѪ֬¡¢ ¸ßѪѹ ¡¢¸ßѪÌDz¢³Æ¡°Ëĸߡ±¡£ ¹ã¶«È˸üÊÇÔÚ¸ßÄòËáµÄÀ×ÇøÉÏ·è¿ñ±ÄµÏ£¬ìÒÌÀ¡¢ºÈ¾Æ¡¢³ÔÉúëç¡¢ìÅÌÇË®£¬Ã¿Ñù»áµ¼Ö¸ßÄòËáµÄÐÐΪ¶¼Ã»ÂäÏ£¬ÄѹÖÓÐË×»°³Æ¡°¶«Î÷Äϱ±ÖУ¬Í´·ç´ó¹ã¶«¡±¡£ ÿÈý¸ö¹ã¶«ÈË£¬¾ÍÓÐÒ»¸ö¸ßÄòËá
¸ßÄòËᣬ²»ÊÇ˵ÄòÊÇËáµÄ¡£ÔÚҽѧÉÏ£¬ËùνµÄ¡°¸ßÄòËᡱ¾ÍÊǸßÄòËáѪ֢£¨hyperuricemia£¬¼ò³ÆHUA£©£¬ÊÇÈËÌåàÑßÊ´úлÒì³£ÒýÆðµÄ´úлÐÔ¼²²¡ [1]¡£ Ò»°ãÇé¿öÏ£¬ÈËÌå²úÉúºÍÅÅйµÄÄòËáÊÇƽºâµÄ¡£µ«µ±àÑßÊ´úл³öÏÖÕÏ°£¬ÄòËáˮƽÉý¸ß£¬¾Í¿ÉÄܵ¼Ö¸ßÄòËáѪ֢¡£ÈËÃdz£ËµµÄ¡°Í´·ç¡±ÊÇÔÚ´Ë»ù´¡ÉϽøÒ»²½·¢Õ¹£¬ÄòËáÑνᾧ³Á»ýÔڹؽڵȴ¦£¬Òý·¢Ñ×Ö¢ºÍ×éÖ¯ËðÉË [1]¡£ Õý³£Òûʳ״̬Ï£¬·ÇͬÈÕÁ½´Î¼ì²â¿Õ¸¹ÑªÄòËáˮƽ´óÓÚ420 ¦Ìmol/L£¬¼´¿ÉÕï¶ÏΪ¸ßÄòËáѪ֢ [1]¡£ ÖйúÈ˵øßÄòËáÓжàÆÕ±éÄØ£¿ Ò»ÏîÉæ¼°177ƪÑо¿¡¢³¬200Íò¸öÑù±¾µÄÜöÝÍÑо¿²âË㣬Öйú15Ëê¼°ÒÔÉϵÄÈËȺԼÓÐ16.4% »¼ÓиßÄòËáѪ֢ [2]¡£ ÆäÖУ¬ÄÐÐÔ»¼²¡±ÈÀýÊÇ20.4%£¬ÊÇÅ®ÐÔ£¨9.8%£©µÄÁ½±¶»¹¸ß¡£Ò²¾ÍÊÇ˵£¬Óг¬¹ýÎå·ÖÖ®Ò»µÄ20µ½30ËêµÄÄÐÉú£¬Äê¼ÍÇáÇáÒѾ¸ßÄòËáÁË [2]¡£ ´ÓÈ«¹úµÄ¸ßÄòËáѪ֢»¼²¡ÂÊÀ´¿´£¬ÕûÌåÊdzÇÊиßÓÚÅ©´å£¬Ñغ£¸ßÓÚÄÚ½ [1]¡£º¬¹ã¶«¡¢¹ãÎ÷¡¢º£ÄÏÔÚÄڵĻªÄϵØÇø×î¸ß£¬Îª25.5%£¬Ï൱ÓÚÿËĸö»ªÄÏÈ˾ÍÓÐÒ»¸ö¸ßÄòËá [2]¡£ Æä´ÎÊÇÎ÷ÄϵØÇø£¬Îª21.2%¡£×îµÍµÄÊÇÎ÷±±µØÇø£¬»¼²¡ÂÊÖ»ÓÐ12.6% [2]¡£ ¾ßÌåµ½¸÷¸öÊ¡·Ý£¬ÁíÒ»ÏîÜöÝÍ·ÖÎö·¢ÏÖ£¬ºþ±±¡¢É½¶«ºÍÉÂÎ÷ÕâÈýÊ¡µÄ¸ßÄòËáѪ֢×ÜÌ廼²¡ÂÊÊÇ×îµÍµÄ£¬²»µ½10%¡£¶ø¸£½¨¡¢¹ã¶«¡¢¹ãÎ÷¡¢½Î÷¡¢¼ªÁÖ¡¢ÁÉÄþ¡¢ÉϺ£Î»¾ÓÇ°ÁУ¬³¬¹ý20% [3]¡£ ÓÈÆäÊǹ㶫¡¢¸£½¨¡¢°²»Õ¡¢¹ãÎ÷¡¢¼ªÁÖµÄÄÐÐÔ£¬³¬¹ý30% ¶¼ÓиßÄòËáѪ֢ [3]¡£ ÕâÆäÖУ¬±»·´¸´Ìá¼°µÄ¹ã¶«ÈËÄòËá¸ßµ½ÓжàÀëÆ×ÄØ£¿ 2021ÄêµÄÒ»ÏîÑо¿³é²éÁËÖéÈý½ÇµØÇø6491Ãû20Ëêµ½99ËêµÄ½¡¿µÌå¼ìÕߣ¬·¢ÏÖ34.05% ¶¼ÓиßÄòËᣬÄÐÉú¸ü¿äÕÅ£¬¸ßÄòËá±ÈÀýΪ41.53% [4]¡£ ¹ã¶«ÉõÖÁÁ¬ÖÐѧÉú¶¼¸ßÄòËá¡£¹ãÖÝÊÐÖÐСѧÎÀÉú½¡¿µ´Ù½øÖÐÐijé²é·¢ÏÖ£¬¹ãÖݳÇÇø¸ßÖÐÉú¸ßÄòËáˮƽ¼ì³öÂʾ¹¸ß´ï50.37%£¬ÅÂÊǸ߿¼Ñ¹Á¦´ó£¬³ÔÁËÌ«¶à¼Ò³¤Í¶Î¹µÄÀÏ»ðö¦ÌÀ [5]¡£ ³ýÁ˹㶫£¬¸£½¨È˵ÄÄòËáÒ²²»ÂäÏ·硣¾ÝÏÃÃÅ´óѧ¹«¹²ÎÀÉúѧԺµÄÑо¿£¬ÏÃÃųÉÄê¾ÓÃñµÄ¸ßÄòËáѪ֢»¼²¡ÂÊΪ27.2%£¬Ò²Ô¶¸ßÓÚÈ«¹úƽ¾ùˮƽ [6]¡£ Ò²ÄѹÖÓÐÈË˵£¬¹ã¶«È˸ßÄòËᣬû׼ÊÇÒòΪ¸£½¨È˳ԶàÁË¡£ ¾Æ¾«ºÍ¹ûÌÇ£¬¸ßÄòËáµÄ¸ü´óÔªÐ×
¸ßÄòËá»á±äµÃÈç´ËÆձ飬ÔÒòºÜ¶àÈËÏë²»µ½£¬ÆäÖÐÖ®Ò»¾ÓÈ»ÊÇag¿·¢_¿·¢Ò»´¥¼´·¢µÄÉú»îˮƽԽÀ´Ô½ºÃÁË¡£ ÔڹŴú£¬¸ßÄòËáÒý·¢µÄÍ´·çÊdzöÁËÃûµÄ¡°µÛÍõ²¡¡±¡£·¨¹ú¹úÍõ·Ò×ËÄÊÀµÄ¸¸ÏµÇ×ÊôºÍÓ¢¹ú¹úÍõÇÇÖÎÈýÊÀµÄº¢×Ó¶¼ÊÇÍ´·çÊܺ¦Õß [7]¡£ ·¢´ï¹ú¼ÒÎÞÂÛÊǸßÄòËỼ²¡ÂÊ£¬»¹ÊÇÍ´·ç»¼²¡ÂÊ£¬¶¼ÆÕ±é¸ßÓÚ·¢Õ¹Öйú¼Ò¡£ÃÀ¹ú¡¢ÈÕ±¾µÄ¸ßÄòËá±ÈÀý¶¼³¬¹ý20%£¬¶øÌ©¹ú¡¢ÍÁ¶úÆäµÈ·¢Õ¹Öйú¼Ò£¬ÕâÒ»Êý×Ö²»µ½15% [8]¡£ Ëæ×ÅÖйú¾¼Ã·¢Õ¹£¬ÕâЩÄêÀ´£¬¸ßÄòËáѪ֢»¼²¡ÂÊÒ²ÔÚÔ½À´Ô½¸ß [2]¡£ Ò»ÏîÃæÏòÖйú31Ê¡·Ý£¨²»º¬Öйú¸Û°Ą̈µØÇø£©¡¢½ü°ËÍòÈ˵ÄÑо¿Í¬Ñù·¢ÏÖ£¬ÄêÊÕÈëÒ»Íòµ½Ê®ÍòÒÔÉϵÄÈËȺÖУ¬¸ßÄòËáѪ֢»òÍ´·ç»¼²¡ÂÊÕûÌ嶼Ëæ×ÅÄêÊÕÈëÔö³¤¶øÔö³¤ [9]¡£ ÄêÊÕÈëÊ®ÍòÔªÒÔÉϵÄÈËȺ£¬¸ßÄòËáѪ֢»¼²¡ÂÊΪ21.4%£¬Òª±ÈÄêÊÕÈëÎåÍòµ½Ê®ÍòÔªµÄÈ˸߳ö3.4¸ö°Ù·Öµã [9]¡£ Ϊʲô»áÈç´Ë£¿ÕâÒª´ÓÄòËáµÄÀ´Ô´ËµÆð¡£ ÄòËáÊÇÓÉàÑßÊ´úл¶ø³ÉµÄ£¬ÌåÄÚµÄÄòËáÓÐ80% À´×ÔÄÚÔ´ÐÔµÄàÑßÊ´úл£¬ÁíÓÐ20% ÊÇÍâÔ´µÄʳÎï²úÉú [10]¡£ ËùÒÔ¿ÉÒÔ˵£¬ÈËÌåÄòËáˮƽ¸ßµÍ£¬Ö±½ÓÊܵ½ÒûʳµÄÓ°Ïì¡£ Ò»·½Ã棬Äã³Ô½øÀ´µÄàÑßʶàÁË£¬´úл¶ø³ÉµÄÄòËáÒ²¾Í¶àÁË¡£±ÈÈçÈâÀà¡¢º£ÏÊ¡¢ÄÚÔà¾ÍÊǵäÐ͵ĸßàÑßÊʳÎï¡£¹ã¶«ÈË°®²»ÊͿڵĶì¸üÊÇàÑßÊ¡°¶¥Á÷¡±£¬Ã¿100¿Ë¶ì¸Î¾ÍÓÐ377ºÁ¿ËàÑßÊ [1]¡£ 2015ÄêÒ»ÏîÃæÏò¸£½¨2666Ãû³ÉÄê¾ÓÃñµÄµ÷²éÒ²·¢ÏÖ£¬Èç¹û½«ÈËÃǵÄÉÅʳģʽ·ÖΪ´«Í³ÐÍ¡¢¶¯ÎïÐÔʳÎïÐÍ¡¢Ñغ£ÐÍ¡¢ÓÅÖʵ°°×ÐÍ£¬ÆäÖж¯ÎïÐÔʳÎïÐͺÍÑغ£ÐÍÈËȺµÄ¸ßÄòËỼ²¡ÂÊÊÇ×î¸ßµÄ£¬ÕâÁ½ÕßÖ÷Òª³ÔµÄ¾ÍÊÇÈâºÍº£ÏÊ [11]¡£ ÁíÒ»·½Ã棬ÓÐЩÉú»îÏ°¹ß±¾Éí²»»áÔö¼ÓÍâÔ´ÐÔàÑßʵÄÉãÈ룬µ«Ó°ÏìÁËÈËÌåµÄ´úл£¬Ò²»áµ¼Ö¸ßÄòËá ¡£ ×îµäÐ͵ľÍÊǺȾơ£¾Æ¾«ËäÈ»²»ÊÇàÑßÊ£¬µ«¾Æ¾«ÔÚÌåÄÚ´úлʱ»áÔö¼ÓÄÚÔ´ÐÔàÑßʵÄÉú³É£¬´Ó¶øÉý¸ßÈËÌåµÄÄòËáˮƽ£¬Î£º¦²»±È¸ßàÑßÊʳÎïС [12]¡£ ´ËÍ⣬¹ûÌǵÄΣº¦Ò²ÈÝÒ×±»ºöÊÓ¡£ËäÈ»Ëü¿´×ÅÈËÐóÎÞº¦£¬µ«¹ýÁ¿ÉãÈëºóÒ²¿ÉÄÜ»áÓÕ·¢ÄòËáˮƽµÄÉý¸ß [2]¡£Éñ¾¿Æѧ¼Ò´÷ά¡¤çê¶ûÂíÌظüÊÇÔÚ¡¶·è¿ñµÄÄòËá¡·Ò»ÊéÖÐÖ±Ö¸£¬¹ýÁ¿µÄ¹ûÌÇÉãÈëÒѾ³ÉÁËÏÖ´úÈ˸ßÄòËáµÄÔªÐ× [13]¡£ ËäȻˮ¹ûÀïÒ²ÓйûÌÇ£¬µ«ÏÖ´úÈ˹ûÌÇÉãÈ볬±êÍùÍù²»ÊÇË®¹ûµÄ¹ø£¬¶øÊÇÒòΪ¹ã·º´æÔÚÓÚ¾«¼Ó¹¤µÄÌðÆ·¡¢ÌðÒûÁÏÖеĹûÌÇ£¬ÀýÈçËæ´¦¿É¼ûµÄ¹ûÆÏÌǽ¬£¬Ö÷Òª³É·Ö±ãÊǹûÌÇ [13]¡£ ³ýÁËÒûʳ£¬µ¼Ö¸ßÄòËáµÄÁíÒ»´ó¡°É±ÊÖ¡±ÊÇ·ÊÅÖ¡£ ·ÊÅÖ»á¸Ä±äÉíÌå´úл£¬ÄÜÔö¼ÓÄòËáÔÚ¸ÎÔàÖеĺϳɡ¢¼õÉÙÔÚÉöÔàÖеÄÅÅй [13]¡£±±¾©ÐºÍÒ½ÔºµÄÑо¿±íÃ÷£¬ÔÚÌåÖ¬ÂÊСÓÚ34.3% µÄÄÐÉúÖУ¬ÌåÖ¬ÂÊÿÉÏÉý1%£¬ÑªÇåÄòËá¾ÍÔö¼Ó1.97 ¦Ìmol/L [14]¡£ ½²µ½ÕâÀ´ð°¸Ò²Öð½¥Ã÷Îú¡£µ¼Ö¸ßÄòËáµÄÖ÷ÒªÒòËظպþÍÊǾ¼Ã·¢´ïµØÇø¾ÓÃñµÄÌص㣺·ÊÅÖÂʸߣ¬Éú»îÌõ¼þºÃ£¬ÈÕ³£Éú»î¾ÍÊÇ´óÓã´óÈâÅäÉÏŨÌÀÃÀ¾Æ¡£ ¸ßÄòËáµÄΣº¦£¬±»ÑÏÖص͹À
Èç½ñ£¬Ðí¶àÄêÇáÈ˱»²é³ö¸ßÄòËᣬµ«ÈÔ²»·ÅÔÚÐÄÉÏ¡£±ð¿´ÄòËáÖ»ÊǸö²»ÆðÑÛµÄÊý×Ö£¬Ò»µ©³ÖÐø¸ß³öÕý³£Ë®Æ½£¬ºó¹û»¹ÊÇÂù¶àµÄ¡£ Ê×ÒªµÄ¾ÍÊÇ´ó¼ÒÊìÖªµÄÍ´·ç¡£ Í´·çÈ«³ÆÊǼ±ÐÔÍ´·çÐԹؽÚÑ×£¬Ö®ËùÒÔ½ÐÍ´·ç£¬¾ÍÒòΪÕâÖÖ²¡ÕæµÄºÜ´õ¶¾£¬¾ÍÏñ·çÒ»°ãÄÑÒÔ×½Ãþ¡£·¢×÷µÄµäÐ͹ý³ÌÊÇÉÏ´²Ë¯¾õʱ»¹ºÃºÃµÄ£¬ºó°ëÒ¹¾ÍÒòΪ½ÅÍ´Í´ÐÑ [1]¡£ ¶øÇÒÍ´·çÍ´ÆðÀ´ºÜÒªÃü¡£Ó¢¹úÖøÃûÂþ»¼Òղķ˹¡¤¼ª¶ûÈðÔÚ1799Äê·¢±íµÄ¡¶Í´·ç¡·Âþ»ÖУ¬°ÑÍ´·çÃè»æ³ÉÒ»¸öÕýÔÚ¿ÐÊÉÈ˽ŵĺÚɫħ¹í£¬ËµËºÐÄÁÑ·ÎÊÇÒ»µãÒ²²»¿äÕÅ [15]¡£ ³ýÁËÌÛÍ´£¬²»×ö½µÄòËáÖÎÁƵĻ°£¬Í´·ç»¼ÕߵĹؽڴ¦»¹»áÒòΪÄòËáÑξ§Ìå³Á»ý³¤³öÍ´·çʯ£¬ÑÏÖصĻ¹»á¹Ø½Ú»ûÐΣ¬ÉõÖÁ¹ÇÕÛ [16]¡£ ²»ÊÇËùÓеĸßÄòËáÈËȺ¶¼»áµÃÍ´·ç£¬µ«¶þÕßÊÇÃÜÇÐÏà¹ØµÄ¡£¸ù¾ÝÎÀ½¡Î¯Í³¼Æ£¬Ã¿100λ¸ßÄòËáѪ֢»¼ÕßÖУ¬Ô¼ÓÐ6µ½16È˻ᷢչΪʹ·ç [1]¡£ ²»Ö»Í´·ç£¬Ô½À´Ô½¶àÑо¿±íÃ÷£¬¸ßÄòËáºÍ¸ßѪѹ¡¢ÐÄÔಡ¡¢ÂýÐÔÉöÔಡ¡¢ÌÇÄò²¡µÈÖî¶àÂýÐÔ²¡Ö®¼ä´æÔÚ¹ØÁª¡£ ÀýÈç¸ßÄòËáˮƽ»áÒý·¢Ò»ÏµÁб»³ÆΪ¡°Ñõ»¯Ó¦¼¤¡±µÄÉú»¯·´Ó¦£¬´Ó¶øµ¼ÖÂѪ¹ÜÊÕËõ£¬Ê¹µÃÐÄÔàÒª¸ü¼ÓŬÁ¦µØ´Ù½øѪҺѻ·£¬ÑªÑ¹Ò²Òò´Ë¶øÉý¸ß [13]¡£ ¸ßÄòËỹ»á·´¹ýÀ´¼Ó¾ç·ÊÅֵķ¢Éú¡£·¢±íÔÚ¡¶ÉúÀíѧÓëÐÐΪѧ¡·ÉϵÄÒ»ÏîÑо¿±íÃ÷£¬ÄòËáµÄ»ý¾Û»áÔöÇ¿¹ûÌǵÄ×÷Óã¬ÒÖÖÆÊÝËØ£¨Ò»ÖÖÈÃÈËÍ£Ö¹½øʳµÄ¼¤ËØ£©·ÖÃÚ£¬´Ó¶ø»ýÀÛ¸ü¶àÖ¬·¾ [17]¡£ 2020Ä꣬ÈÕ±¾É½ÐδóѧÖ÷µ¼µÄÒ»ÏîÑо¿ÖУ¬Ñо¿ÈËÔ±ÓÃÆßÄêʱ¼ä¸ú×Ùµ÷²é50¶àÍòÈË£¬·¢ÏÖ¸ßÄòËáˮƽ»áÏÔÖøÔö¼ÓËÀÍö·çÏÕ [18]¡£ µ±È»£¬Òª±ÜÃâ¸ßÄòËᣬ·½·¨»¹ÊǺܶàµÄ¡£ Ò»¸ö¾ÍÊÇҪעÒâÒûʳ¡£¶à³ÔÊ߲ˣ¬¼õÉپƾ«ºÍ¹ûÌÇÉãÈë¡£¿ÉÒÔÊÊÁ¿ÒûÓõÍÖ¬¡¢ÍÑ֬ţÄ̼°ÈéÖÆÆ·£¬¾¡Á¿²»ºÈ¿ÉÀÖ¡¢³ÈÖ¡¢Æ»¹ûֵȺ¬¹ûÌÇÒûÁÏ»òº¬ÌÇÈíÒûÁÏ [19]¡£ ÒѾ±»¼ì²â³öÄòËá¸ßµÄÈË»¹ÒªÉÙ³ÔЩº£ÏʺÍÈ⣬¿´×Å×̲¹µÄÀÏĸ¼¦ÌÀ£¬Ã»×¼¾ÍÊÇÒ»Íë¡°àÑßÊÕ¨µ¯¡±¡£ ´ËÍ⣬¶àÔ˶¯¡¢×ãÁ¿ºÈˮҲ¶Ô½µÄòËáÓаïÖú£¬Ç°Õß¿ÉÒÔ°ïÖú¿ØÖÆÌåÖØ£¬ºóÕß¿ÉÒÔ¼Ó¿ìÄòËáÅÅй [1]¡£ ×ܶøÑÔÖ®£¬Ö»Òª¹Üס×죬Âõ¿ªÍÈ£¬¶ÌÔÝÉý¸ßµÄÄòËỹÊǺܿÉÄܽµÏÂÀ´µÄ¡£Ö»¿Éϧ£¬ºÃ³ÔµÄ¶«Î÷Æ«Æ«´ó¶àÊý¶¼²»½¡¿µ£¬Ò²Ðí±£³Ö½¡¿µµÄ±Ø±¸Ì츳£¬³ýÁËÄܶ¯ÄÜ˯ÒÔÍ⣬»¹ÒªÃ»ÓÐζ¾õ¡£
±¾ÎÄ¿ÆѧÐÔÒÑÓÉÅ®Íõ´óѧ²¡Àí¼°·Ö×Óҽѧ˶ʿ ÎéÀöÇà ÉóºË
²Î¿¼×ÊÁÏ [1] ¹ú¼ÒÎÀÉú½¡¿µÎ¯. (2024). ³ÉÈ˸ßÄòËáѪ֢ÓëÍ´·çʳÑøÖ¸ÄÏ. [2] Li, Y., Shen, Z., Zhu, B., Zhang, H., Zhang, X., & Ding, X. (2021). Demographic, regional and temporal trends of hyperuricemia epidemics in mainland of China from 2000 to 2019: a systematic review and meta-analysis. Global health action, 14(1), 1874652. [3] Huang, J., Ma, Z. F., Zhang, Y., Wan, Z., Li, Y., Zhou, H., ... & Lee, Y. Y. (2020). Geographical distribution of hyperuricemia in mainland of China: a comprehensive systematic review and meta-analysis. Global Health Research and Policy, 5, 1-18. [4] Liu, W., Liu, W., Wang, S., Tong, H., Yuan, J., Zou, Z., ... & Xie, Z. (2021). Prevalence and risk factors associated with hyperuricemia in the Pearl River Delta, Guangdong Province, China. Risk Management and Healthcare Policy, 655-663. [5] µËðØ, & ¶ÅÑ©Ó¨. (2019). ¹ãÖݳÇÇø¸ßÖÐÉúѪÄòËáˮƽ¼°Ó°ÏìÒòËØ·ÖÎö. ÖйúѧУÎÀÉú, 40(9), 1420-1422. [6] »Æ¼ÑÀÖ, ÍõÐÂÔÂ, & ÀîºìÎÀ. (2019). ÏÃÃÅÊоÓÃñ¸ßÄòËáѪ֢ÓëÉÅʳàÑßÊÉãÈëµÄÏà¹ØÐÔÑо¿. Acta Nutrimenta Sinica, 41(1). [7] Bhattacharjee, S. (2009). A brief history of gout. International Journal of Rheumatic Diseases, 12(1), 61-63. [8] She, D., Wang, Y., Liu, J., Luo, N., Feng, S., Li, Y., ... & Zhang, Z. (2022). Changes in the prevalence of hyperuricemia in clients of health examination in Eastern China, 2009 to 2019. BMC Endocrine Disorders, 22(1), 202. [9] Song, J., Jin, C., Shan, Z., Teng, W., & Li, J. (2022). Prevalence and risk factors of hyperuricemia and gout: a cross-sectional survey from 31 provinces in mainland of China. Journal of translational internal medicine, 10(2), 134-145. [10] Zhang, M., Wang, Y., Wang, K., Yin, R., Pan, X., & Ma, A. (2021). Association between uric acid and the prognosis of acute ischemic stroke: A systematic review and meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases, 31(11), 3016-3023. [11] ÁÖÉÙ¿, ÀµÉÆéÅ, »Æá¿, ÑôÀö¾ý, & Îâ»Ûµ¤. (2018). ¸£½¨Ê¡¾ÓÃñÉÅʳģʽ¼°¸ßÄòËáѪ֢ӰÏìÒòËØ·ÖÀàÊ÷·ÖÎö. Öйú¹«¹²ÎÀÉú, 34(6), 798-802. [12] Li, R., Yu, K., & Li, C. (2018). Dietary factors and risk of gout and hyperuricemia: a meta-analysis and systematic review. Asia Pacific journal of clinical nutrition, 27(6), 1344-1356. [13] ´÷ά¡¤çê¶ûÂíÌØ. (2023). ·è¿ñµÄÄòË᣺²»Ö¹ÊÇÍ´·ç. ±±¾©¿Æѧ¼¼Êõ³ö°æÉç. [14] Sun, J., Yue, C., Liu, Z., Li, J., & Kang, W. (2022). The association between total percent fat and serum uric acid in adults. Frontiers in Nutrition, 9, 851280. [15] James Gillray. (1799). The gout. National Portrait Gallery. Retrieved on August 8th, 2024, from https://www.npg.org.uk/collections/search/portrait/mw62371/The-gout. [16] Áõ¾², ³Â«hÇÅ, ³ÂÇïÖ¾, ì¶Ò»·², Áõ°ÁÄÐ, Ö£ÎäÑà, ÂÀÍòƼ, ¹ùÒÔ´¨, & ÑîÑÞ·¼. (2022). Í´·ç»¼ÕßÍ´·çʯÐγÉÏÖ×´¼°Ïà¹ØÒòËØ·ÖÎö. ÏÖ´úÔ¤·Àҽѧ, 2022, 49(17):3252-3259. [17] Figlewicz, D. P., Ioannou, G., Jay, J. B., Kittleson, S., Savard, C., & Roth, C. L. (2009). Effect of moderate intake of sweeteners on metabolic health in the rat. Physiology & Behavior, 98(5), 618-624. [18] Konta, T., Ichikawa, K., Kawasaki, R., Fujimoto, S., Iseki, K., Moriyama, T., ... & Watanabe, T. (2020). Association between serum uric acid levels and mortality: a nationwide community-based cohort study. Scientific reports, 10(1), 6066. [19] ¹ú¼ÒÎÀÉú½¡¿µÎ¯. (2023). ³ÉÈ˸ßÄòËáѪ֢ÓëÍ´·çʳÑøÖ¸ÄϱàÖÆ˵Ã÷.